Annual EBITDA
-$19.85 M
+$3.05 M+13.32%
December 1, 2024
Summary
- As of March 13, 2025, NVCT annual EBITDA is -$19.85 million, with the most recent change of +$3.05 million (+13.32%) on December 1, 2024.
- During the last 3 years, NVCT annual EBITDA has fallen by -$6.95 million (-53.92%).
- NVCT annual EBITDA is now -53.92% below its all-time high of -$12.89 million, reached on December 31, 2021.
Performance
NVCT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$6.45 M
-$2.09 M-47.95%
December 1, 2024
Summary
- As of March 13, 2025, NVCT quarterly EBITDA is -$6.45 million, with the most recent change of -$2.09 million (-47.95%) on December 1, 2024.
- Over the past year, NVCT quarterly EBITDA has stayed the same.
- NVCT quarterly EBITDA is now -27939.13% below its all-time high of -$23.00 thousand, reached on March 31, 2021.
Performance
NVCT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$19.85 M
+$417.00 K+2.06%
December 1, 2024
Summary
- As of March 13, 2025, NVCT TTM EBITDA is -$19.85 million, with the most recent change of +$417.00 thousand (+2.06%) on December 1, 2024.
- Over the past year, NVCT TTM EBITDA has stayed the same.
- NVCT TTM EBITDA is now -86191.30% below its all-time high of -$23.00 thousand, reached on March 31, 2021.
Performance
NVCT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVCT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.3% | 0.0% | 0.0% |
| 3 y3 years | -53.9% | -4.7% | +13.0% |
| 5 y5 years | - | -4.7% | +13.0% |
NVCT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -53.9% | +13.3% | -184.7% | +6.1% | -53.9% | +14.4% |
| 5 y | 5-year | -53.9% | +13.3% | <-9999.0% | +6.1% | <-9999.0% | +14.4% |
| alltime | all time | -53.9% | +13.3% | <-9999.0% | +6.1% | <-9999.0% | +14.4% |
Nuvectis Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$19.85 M(-13.3%) | -$6.45 M(+47.9%) | -$19.85 M(-2.1%) |
| Sep 2024 | - | -$4.36 M(-6.1%) | -$20.26 M(-8.2%) |
| Jun 2024 | - | -$4.64 M(+5.6%) | -$22.06 M(-4.9%) |
| Mar 2024 | - | -$4.40 M(-36.0%) | -$23.19 M(+1.3%) |
| Dec 2023 | -$22.90 M(+19.0%) | -$6.87 M(+11.5%) | -$22.90 M(+0.4%) |
| Sep 2023 | - | -$6.16 M(+6.7%) | -$22.81 M(+1.0%) |
| Jun 2023 | - | -$5.77 M(+40.7%) | -$22.59 M(+10.8%) |
| Mar 2023 | - | -$4.10 M(-39.5%) | -$20.39 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$19.23 M(+49.2%) | -$6.78 M(+14.1%) | -$19.23 M(+30.7%) |
| Sep 2022 | - | -$5.94 M(+66.2%) | -$14.72 M(+9.4%) |
| Jun 2022 | - | -$3.57 M(+21.3%) | -$13.45 M(-15.0%) |
| Mar 2022 | - | -$2.94 M(+30.0%) | -$15.82 M(+22.7%) |
| Dec 2021 | -$12.89 M | -$2.27 M(-51.5%) | -$12.89 M(+21.3%) |
| Sep 2021 | - | -$4.67 M(-21.4%) | -$10.63 M(+78.3%) |
| Jun 2021 | - | -$5.94 M(>+9900.0%) | -$5.96 M(>+9900.0%) |
| Mar 2021 | - | -$23.00 K | -$23.00 K |
FAQ
- What is Nuvectis Pharma annual EBITDA?
- What is the all time high annual EBITDA for Nuvectis Pharma?
- What is Nuvectis Pharma annual EBITDA year-on-year change?
- What is Nuvectis Pharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly EBITDA year-on-year change?
- What is Nuvectis Pharma TTM EBITDA?
- What is the all time high TTM EBITDA for Nuvectis Pharma?
- What is Nuvectis Pharma TTM EBITDA year-on-year change?
What is Nuvectis Pharma annual EBITDA?
The current annual EBITDA of NVCT is -$19.85 M
What is the all time high annual EBITDA for Nuvectis Pharma?
Nuvectis Pharma all-time high annual EBITDA is -$12.89 M
What is Nuvectis Pharma annual EBITDA year-on-year change?
Over the past year, NVCT annual EBITDA has changed by +$3.05 M (+13.32%)
What is Nuvectis Pharma quarterly EBITDA?
The current quarterly EBITDA of NVCT is -$6.45 M
What is the all time high quarterly EBITDA for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly EBITDA is -$23.00 K
What is Nuvectis Pharma quarterly EBITDA year-on-year change?
Over the past year, NVCT quarterly EBITDA has changed by $0.00 (0.00%)
What is Nuvectis Pharma TTM EBITDA?
The current TTM EBITDA of NVCT is -$19.85 M
What is the all time high TTM EBITDA for Nuvectis Pharma?
Nuvectis Pharma all-time high TTM EBITDA is -$23.00 K
What is Nuvectis Pharma TTM EBITDA year-on-year change?
Over the past year, NVCT TTM EBITDA has changed by $0.00 (0.00%)